Recurrent inflammation in a site of previous necrotising fasciitis during intravenous CMF chemotherapy.
We present the case history of a patient with breast carcinoma who developed repeated inflammation at the site of previous necrotising fasciitis following each cycle of intravenous CMF chemotherapy. This complication has not previously been reported.
Mackay
H J
HJ
Beatson Oncology Centre, Western Infirmary, Glasgow, UK. hjmklz@udcf.gla.ac.uk
Williamson
E C
EC
Vasey
P
P
Harnett
A N
AN
D000005:Abdomen / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy; D002921:Cicatrix; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D019115:Fasciitis, Necrotizing / Q000150:complications* / Q000473:pathology; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged
D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate